Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting
Journal
-
- Lung Cancer
-
Lung Cancer 89 (2), 161-166, 2015-08
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1361981468638657920
-
- ISSN
- 01695002
-
- Data Source
-
- Crossref